Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for OABI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 260.27M
March 31, 2026 262.65M
December 31, 2025 267.03M
September 30, 2025 277.44M
June 30, 2025 262.06M
March 31, 2025 273.52M
December 31, 2024 287.62M
September 30, 2024 291.73M
June 30, 2024 294.18M
March 31, 2024 301.39M
December 31, 2023 314.58M
Date Value
September 30, 2023 324.55M
June 30, 2023 333.81M
March 31, 2023 340.80M
December 31, 2022 341.37M
September 30, 2022 223.32M
June 30, 2022 221.76M
March 31, 2022 223.39M
December 31, 2021 234.31M
September 30, 2021 228.85M
June 30, 2021 0.015M
March 31, 2021 0.0172M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
IQVIA Holdings, Inc. 6.171B
Champions Oncology, Inc. 3.939M
Medpace Holdings, Inc. 433.86M
Charles River Laboratories International, Inc. 2.840B
Avantor, Inc. 5.630B

Shareholders Equity (Quarterly) Related Metrics